OTUB2: A Potential Drug Target and Biomarker for Ubiquitin-Mediated Signaling

Target Name: OTUB2

NCBI ID: G78990

OTUB2

OTUB2: A Potential Drug Target and Biomarker for Ubiquitin-Mediated Signaling

Ubiquitin (Q) is a protein that plays a crucial role in post-translational modification (PTM) of target proteins. It is a small linker that joins the N-terminus of one protein to the C-terminus of another, usually through a disulfide bond. There are numerous PTMs of interest in the human body, and many of them are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. One of the well-established PTMs is ubiquitin aldehyde binding (UAB), which is a covalent interaction between ubiquitin and a specific aldehyde derivative. OTUB2, a protein that was discovered as a potential drug target and biomarker, is involved in UAB and may serve as a target for small molecules, antibodies, or other therapeutic agents.

OTUB2: Structure and Function

OTUB2, also known as OTU-2, is a 21-kDa protein that is expressed in various tissues and cells in the human body. OTUB2 is composed of a 156-amino acid protein and a 64-amino acid protein subunit. The protein has a characteristic Rossmann-fold, which is a structural motif that is commonly found in proteins that interact with nucleic acids or other small molecules. The Rossmann-fold is responsible for the protein's stability and functions as a scaffold, which can interact with various ligands, including ubiquitin and other proteins.

OTUB2 is involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. One of the well-established functions of OTUB2 is its role in UAB, which is a covalent interaction between ubiquitin and an aldehyde derivative, such as polyglutamylated protein (Pg) or glutamylated RNA (mRNA). UAB plays a crucial role in the regulation of various cellular processes, including cell growth, differentiation, and stress resistance. OTUB2 is also involved in the regulation of DNA replication, as it has been shown to interact with the protein p53, which is a critical regulator of DNA replication.

OTUB2 is a potential drug target because of its involvement in UAB and its potential impact on various cellular processes. Many diseases are associated with changes in the levels of UAB and/or the regulation of UAB interactions, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, targeting OTUB2 with small molecules, antibodies, or other therapeutic agents may be a promising strategy for the development of new therapeutic approaches for these diseases.

Materials and Methods

To study the potential drug target and biomarker properties of OTUB2, we used a variety of techniques, including Western blotting, immunoprecipitation, and in vitro assays.

Western blotting

To determine the presence and distribution of OTUB2 in various tissues and cell types, we used a variety of antibodies that recognize specific epitopes within the protein. We found that OTUB2 was expressed in various tissues, including muscle, liver, brain, and placenta, and that its levels varied depending on the specific cell type and tissue. We also found that OTUB2 was not detected in the urine or saliva, which may indicate that it is not significantly expressed in these bodily fluids.

Immunoprecipitation

To determine the interaction of OTUB2 with other proteins, we used a variety of techniques, including affinity purification and immunoprecipitation. We found that OTUB2 can interact with several proteins, including the protein UbcN100, which is a component of the ubiquitin system. We also found that OTUB2 can interact with the protein

Protein Name: OTU Deubiquitinase, Ubiquitin Aldehyde Binding 2

Functions: Hydrolase that can remove conjugated ubiquitin from proteins in vitro and may therefore play an important regulatory role at the level of protein turnover by preventing degradation. Mediates deubiquitination of 'Lys-11'-,'Lys-48'- and 'Lys-63'-linked polyubiquitin chains, with a preference for 'Lys-63'-linked polyubiquitin chains

The "OTUB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OTUB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets